The Discordance of Gene Mutations Between Circulating Tumor Cells and Primary/Metastatic Tumor

Molecular Therapy - Oncolytics - United Kingdom
doi 10.1016/j.omto.2019.08.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pancreatic Cancer: Circulating Tumor Cells and Primary Tumors Show Heterogeneous KRAS Mutations

Scientific Reports
Multidisciplinary
2017English

Lymph‐circulating Tumor Cells Show Distinct Properties to Blood‐circulating Tumor Cells and Are Efficient Metastatic Precursors

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Association Between Circulating Tumor Cells and Peripheral Blood Monocytes in Metastatic Breast Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Stemness Gene Profiles of Circulating Tumor Cells

Journal of Cancer Therapy
2017English

Detection of Circulating Tumor Cells: Clinical Relevance of a Novel Metastatic Tumor Marker

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2011English

Circulating Tumor Cells

JAMA Oncology
Cancer ResearchOncology
2015English

Circulating Tumor Cells in Breast Cancer Beyond the Genotype of Primary Tumor for Tailored Therapy

International Journal of Cancer
Cancer ResearchOncology
2015English

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma

Cancers
Cancer ResearchOncology
2019English

Circulating Tumor and Endothelial Cells as Predictors of Response in Metastatic Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy